Cytosorbents Corp
NASDAQ:CTSO

Watchlist Manager
Cytosorbents Corp Logo
Cytosorbents Corp
NASDAQ:CTSO
Watchlist
Price: 0.97 USD 4.3% Market Closed
Market Cap: 52.8m USD
Have any thoughts about
Cytosorbents Corp?
Write Note

Intrinsic Value

CTSO's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one CTSO stock under the Base Case scenario is 1.85 USD. Compared to the current market price of 0.97 USD, Cytosorbents Corp is Undervalued by 48%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CTSO Intrinsic Value
1.85 USD
Undervaluation 48%
Intrinsic Value
Price
Base Case Scenario

Valuation Backtest
Cytosorbents Corp

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for CTSO cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about CTSO?
Bearish
Neutral
Bullish

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Cytosorbents Corp

Provide an overview of the primary business activities
of Cytosorbents Corp.

What unique competitive advantages
does Cytosorbents Corp hold over its rivals?

What risks and challenges
does Cytosorbents Corp face in the near future?

Has there been any significant insider trading activity
in Cytosorbents Corp recently?

Summarize the latest earnings call
of Cytosorbents Corp.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Cytosorbents Corp.

Provide P/S
for Cytosorbents Corp.

Provide P/E
for Cytosorbents Corp.

Provide P/OCF
for Cytosorbents Corp.

Provide P/FCFE
for Cytosorbents Corp.

Provide P/B
for Cytosorbents Corp.

Provide EV/S
for Cytosorbents Corp.

Provide EV/GP
for Cytosorbents Corp.

Provide EV/EBITDA
for Cytosorbents Corp.

Provide EV/EBIT
for Cytosorbents Corp.

Provide EV/OCF
for Cytosorbents Corp.

Provide EV/FCFF
for Cytosorbents Corp.

Provide EV/IC
for Cytosorbents Corp.

Show me price targets
for Cytosorbents Corp made by professional analysts.

What are the Revenue projections
for Cytosorbents Corp?

How accurate were the past Revenue estimates
for Cytosorbents Corp?

What are the Net Income projections
for Cytosorbents Corp?

How accurate were the past Net Income estimates
for Cytosorbents Corp?

What are the EPS projections
for Cytosorbents Corp?

How accurate were the past EPS estimates
for Cytosorbents Corp?

What are the EBIT projections
for Cytosorbents Corp?

How accurate were the past EBIT estimates
for Cytosorbents Corp?

Compare the revenue forecasts
for Cytosorbents Corp with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Cytosorbents Corp and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Cytosorbents Corp against its competitors.

Analyze the profit margins
(gross, operating, and net) of Cytosorbents Corp compared to its peers.

Compare the P/E ratios
of Cytosorbents Corp against its peers.

Discuss the investment returns and shareholder value creation
comparing Cytosorbents Corp with its peers.

Analyze the financial leverage
of Cytosorbents Corp compared to its main competitors.

Show all profitability ratios
for Cytosorbents Corp.

Provide ROE
for Cytosorbents Corp.

Provide ROA
for Cytosorbents Corp.

Provide ROIC
for Cytosorbents Corp.

Provide ROCE
for Cytosorbents Corp.

Provide Gross Margin
for Cytosorbents Corp.

Provide Operating Margin
for Cytosorbents Corp.

Provide Net Margin
for Cytosorbents Corp.

Provide FCF Margin
for Cytosorbents Corp.

Show all solvency ratios
for Cytosorbents Corp.

Provide D/E Ratio
for Cytosorbents Corp.

Provide D/A Ratio
for Cytosorbents Corp.

Provide Interest Coverage Ratio
for Cytosorbents Corp.

Provide Altman Z-Score Ratio
for Cytosorbents Corp.

Provide Quick Ratio
for Cytosorbents Corp.

Provide Current Ratio
for Cytosorbents Corp.

Provide Cash Ratio
for Cytosorbents Corp.

What is the historical Revenue growth
over the last 5 years for Cytosorbents Corp?

What is the historical Net Income growth
over the last 5 years for Cytosorbents Corp?

What is the current Free Cash Flow
of Cytosorbents Corp?

Discuss the annual earnings per share (EPS)
trend over the past five years for Cytosorbents Corp.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Cytosorbents Corp

Current Assets 22m
Cash & Short-Term Investments 8.5m
Receivables 7.8m
Other Current Assets 5.7m
Non-Current Assets 31.5m
PP&E 21.2m
Other Non-Current Assets 10.3m
Current Liabilities 10.3m
Accounts Payable 3m
Accrued Liabilities 6m
Other Current Liabilities 1.3m
Non-Current Liabilities 26.4m
Long-Term Debt 13.7m
Other Non-Current Liabilities 12.7m
Efficiency

Earnings Waterfall
Cytosorbents Corp

Revenue
37.2m USD
Cost of Revenue
-13.2m USD
Gross Profit
24m USD
Operating Expenses
-48.1m USD
Operating Income
-24.1m USD
Other Expenses
-1.4m USD
Net Income
-25.5m USD

Free Cash Flow Analysis
Cytosorbents Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

CTSO Profitability Score
Profitability Due Diligence

Cytosorbents Corp's profitability score is 22/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Revenue Growth Forecast
ROIC is Increasing
Positive 1-Year Revenue Growth
22/100
Profitability
Score

Cytosorbents Corp's profitability score is 22/100. The higher the profitability score, the more profitable the company is.

CTSO Solvency Score
Solvency Due Diligence

Cytosorbents Corp's solvency score is 34/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Low D/E
Long-Term Solvency
Positive Net Debt
34/100
Solvency
Score

Cytosorbents Corp's solvency score is 34/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CTSO Price Targets Summary
Cytosorbents Corp

Wall Street analysts forecast CTSO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CTSO is 5.1 USD with a low forecast of 1.01 USD and a high forecast of 10.5 USD.

Lowest
Price Target
1.01 USD
4% Upside
Average
Price Target
5.1 USD
426% Upside
Highest
Price Target
10.5 USD
982% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for CTSO?

Click here to dive deeper.

Dividends

Cytosorbents Corp
does not pay dividends
Shareholder Yield

Current shareholder yield for CTSO is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

CTSO Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Cytosorbents Corp Logo
Cytosorbents Corp

Country

United States of America

Industry

Health Care

Market Cap

52.7m USD

Dividend Yield

0%

Description

CytoSorbents Corp. engages in the critical care immunotherapy, investigation, and commercialization of blood purification technology. The company is headquartered in Monmouth Junction, New Jersey and currently employs 221 full-time employees. The company went IPO on 2005-06-17. The firm is engaged in the treatment of life-threatening conditions in the intensive care (ICU) and cardiac surgery using blood purification via its polymer adsorption technology. The firm's lead product, CytoSorb, is an extracorporeal cytokine absorber, designed to reduce the cytokine storm or cytokine release syndrome that could otherwise cause massive inflammation, organ failure and death in common critical illnesses such as sepsis, burn injury, trauma, lung injury, cytokine release syndrome due to cancer immunotherapy and pancreatitis. Its other products include animal-targeted VetResQ, DrugSorb-ATR and ECOS-300CY. The firm's product candidates under development includes CytoSorb XL, BetaSorb, ContrastSorb, DrugSorb, HemoDefend-RBC, HemoDefend-BGA, K+ontrol, and others consist of a cartridge containing adsorbent and porous polymer beads.

Contact

NEW JERSEY
Monmouth Junction
7 Deerpark Dr Ste K
cytosorbents.com

IPO

2005-06-17

Employees

221

Officers

CEO & Director
Dr. Phillip P. Chan M.D., Ph.D.
President & COO
Mr. Vincent J. Capponi M.S.
Chief Financial Officer
Ms. Kathleen P. Bloch CPA, M.B.A.
Chief Medical Officer
Dr. Efthymios N. Deliargyris FACC, FESC, FSCAI, M.D.
Vice President of Investor Relations & Corporate Communications
Ms. Terri Anne Powers M.B.A.
Executive Vice President of Sales & Marketing
Dr. Christian Steiner M.D.
Show More
Senior Vice President of Business Development
Mr. Christopher Cramer M.B.A., M.S.
Executive
Jodi Hoover
Co-Chairman of Cardiac Surgery Advisory Board & Consultant
Dr. Robert H. Bartlett M.D.
Show Less

See Also

Discover More
What is the Intrinsic Value of one CTSO stock?

The intrinsic value of one CTSO stock under the Base Case scenario is 1.85 USD.

Is CTSO stock undervalued or overvalued?

Compared to the current market price of 0.97 USD, Cytosorbents Corp is Undervalued by 48%.

Back to Top